1Agrawal R, Gomez-Pinilla F. "Metabolic syndrome" in the brain:Deficiency in omega-3-fatty acid exacerbates dysfunctions ininsulin receptor signaling and cognition[J]. J Physiol, 2012, 590(ptl0):2485-2499.
2Hashimoto M, Hossain S.Neuroprotective and AmeliorativeActions of Polyunsaturated Fatty Acids Against NeuronalDiseases: Beneficial Effect of Docosahexaenoic Acid onCognitive Decline in Alzheimer’s Disease[J]. J Pharmacol Sci,2011,116(2):150-162.
3Hirashima F, Parow AM, Stoll AL, et al. Omega-3 fatty acidtreatment and T2 whole brain relaxation times in bipolar disorder[J]. Am J Psychiatry,2004, 161 (10): 1922- 1924.
4Freeman MP, Rapaport MH. Omega-3 fatty acids anddepression: from cellular mechanisms to clinical care [J]. J ClinPsychiatry, 2011, 72( 2 ): 258 - 259 .
5Lebbadi M,Julien C, Phivilay A, et al. Endogenous Conversionof Omega-6 into Omega-3 Fatty Acids Improves Neuropathologyin an Animal Model of Alzheimer’s Disease[J]. J Alzheimers Dis,2011,27(4):853-869.
6Boneva NB, Kikuchi M, Minabe Y, et al. Neuroprotective andAmeliorative Actions of Polyunsaturated Fatty Acids AgainstNeuronal Diseases: Implication of Fatty Acid - Binding Proteins(FABP) and G Protein-Coupled Receptor 40 (GPR40) in AdultNeurogenesis[J].J Pharmacol Sci, 2011, 116( 2) : 163-172.
7He C, Qu X,Cui L, et al. Improved spatial learning performanceof fat-1 mice is associated with enhanced neurogenesis andneuritogenesis by docosahexaenoic acid[J]. Proc Natl Acad SciUSA, 2009,106(27) :11370 — 11375.
8Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acidpromotes neurogenesis in vitro and in vivo[J]. Neuroscience,2006,139(3):991 - 997.
9Calderon F, Kim HY. Role of RXR in neurite outgrowth inducedby docosahexaenoic acid [J], Prostaglandins Leukotrienes EssentFatty Acids,2007, 77(5 - 6): 227-232 .
10Florent-B6chard S, Malaplate-Armand C, Koziel V,et al.Towards a nutritional approach for prevention of Alzheimer’ sdisease: biochemical and cellular aspectsfj]. J Neurol Sci, 2007,262(1-2) :27 - 36.
2Sethom MM, Fares S, Bouaziz N, et al. Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia [J]. Prostaglandins Leukot rienes Essent Fatty Acids, 2010.83 (3): 131 - 136.
3Assies J, Mocking R J, Pouwer F. Maternal depression and child development after prenatal DHA supplementation [J]. JAMA, 2011. 305(4): 360; author reply 360-361.
4Jans LA, Giltay E J, van der Does AJ. The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression [J]. Br J Nutr, 2010. 104(11): 1577-1585.
5Freeman MP, Rapaport MH. Omega-3 fatty acids and depres- sion: from cellular mechanisms to clinical care [J]. J Clin Psychiatry, 2011, 72(2): 258-259.
6Bousquet M, Gue K, Emond V, et al. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkin- son's disease [J]. J Lipid Res, 2011, 52(2): 263-271.
8Decsi T, Koletzko B. Fatty acid composition oi plasma lipid classes in healthy subjects from birth to young adulthood [J]. Eur J Pediatr, 1994, 1153(7): 520-525.
9Sliwinski S, Croonenberghs J, Christophc A, et al. Polyunsatu- rated fatty acids: do they have a role in the pathophysiology of autism [J]. Neuro Endocrinol Lett, 2006, 27(4): 465-471.
10Bell J, LIVlacKinlay E, Dick J, et" al. Essential fatty acids and phospholipase A2 in autistic spectrum disorders [J]. Prostaglan- dins Leukot rienes Essent Fatty Acids, 2004, 71(4): 201-204.
